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Abstract
Background: Acquired neurogenic stuttering has been considered a fairly uncommon clinical occurrence; speech-activated myoclonus is a rare entity that can
mimic stuttering and is caused by a wide array of etiologies.
Case Report: Here we report a patient with myoclonus–dystonia syndrome (MDS), due to an identified disease-causing mutation, who displayed speech-activated
myoclonus mimicking stuttering.
Discussion: In MDS, myoclonus has only infrequently been reported to affect speech. This case further expands the spectrum of conditions causing the rare
clinical phenomenon of speech-activated myoclonus.
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Introduction
Stuttering consists of frequent repetitions, prolongations, or
interruptions of sounds or syllables that disrupt the prosody of
speech.1,2 Acquired neurogenic stuttering has been considered a fairly
uncommon clinical occurrence, though Theys et al.3 report a 5.3%
incidence in their study of 319 stroke patients. The neural substrate of
acquired neurogenic stuttering remains elusive, in large part because of
the myriad brain structures and varied etiologies implicated.1,4
Speech-activated myoclonus is a rare entity that can mimic stuttering
and, like stuttering and other forms of myoclonus, is caused by a wide
array of etiologies, most of which are acquired: neurodegenerative
disease,5 clozapine,5,6 pharyngitis,5 reading epilepsy,7 reflex seizures in
the context of juvenile myoclonic epilepsy,7,8 localization-related
epilepsy secondary to hypoxic brain injury,9 Lance–Adams syn-
drome,10 and as an unclear consequence of primary intestinal T-cell
non-Hodgkin’s lymphoma.11 Here we report a patient with genetic
dystonia, myoclonus–dystonia syndrome (MDS), with an identified
disease-causing mutation who presented with speech-activated myo-
clonus mimicking stuttering.
Case report
A 45-year-old Caucasian male with a history of dystonia presented
to our movement disorders clinic for further evaluation and manage-
ment of his condition. The patient reported that his symptoms started
at age 15 after a diving accident in which he sustained a head injury
that resulted in 10 minutes of unconsciousness. Following that
accident, he suffered gradually progressive neck stiffness and retro-
collis. Carbidopa–levodopa and botulinum toxin were ineffective
treatments for his cervical dystonia. The patient drank alcohol
occasionally, with resultant partial amelioration of his neck stiffness.
In addition to his cervical dystonia, the patient noted some mild jerky
movements in both of his arms. Around age 40, he developed onset of
slowly progressive insuppressible facial twitching, which resulted in
dysarthria and dysphagia.
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The patient’s prenatal history was unremarkable, and he met all
milestones without any delay. However, in high school he was
apparently labeled with a learning disability and was also thought to
have attention deficit disorder, although he did not recall treatment
with stimulants. He had no symptoms of obsessive-compulsive
disorder. Of note, the patient did not have a history of significant
exposure to heavy metals or chemicals.
The patient had a very strong family history of abnormal
movements: myoclonus in his paternal grandmother and two sons
(in their 20s), dystonia in his paternal grandmother’s brother, and
genetically proven MDS (previously known as DTY11) in his sister.
His sister had a similar but more severe phenotype of myoclonus–
dystonia; she did not exhibit any speech-activated myoclonus. Genetic
testing identified a known disease-causing mutation in the epsilon-
sarcoglygan (SGCE) gene: IVS1+1 GRA. This sequence change
abolishes the splice donor site in the first intron and was previously
reported in a large pedigree where this mutation cosegregated with
MDS.12 The patient’s father was apparently unaffected. The patient
had one nephew (son of his affected sister) in his early 20s described as
having obsessive-compulsive disorder, though he did not display any
abnormal movements.
Neurological examination (Video 1) revealed hypokinetic dysarthria
during spontaneous speech. While reading, his speech was abruptly
interrupted by synchronous myoclonic movements affecting his neck
(causing slight lateral head rotation to the right), bilateral orbicularis
oculi, and vocal musculature. The patient continued to exhibit
stuttering-like speech while reading even when no visible myoclonus
was evident, presumably as a result of myoclonus in his vocal
musculature. His speech was most affected while reading aloud, with
much less prominent speech disruption during spontaneous vocaliza-
tion. The patient’s facial expression was normal between myoclonic
jerks. He demonstrated moderate–severe retrocollis and mild later-
ocollis to the left, with significant hypertrophy of the trapezius muscles
bilaterally; even passive flexion of the head was quite painful and
limited. He did not have dystonia affecting any other body segments.
The patient demonstrated subtle myoclonic jerks in his distal arms
bilaterally, both asynchronous and synchronous. He had some
difficulties with tandem gait.
The patient was offered deep brain stimulation,13 but he declined
and was subsequently lost to follow-up. Electrophysiological investiga-
tions were unable to be obtained as a result.
Discussion
MDS is a heterogeneous clinical entity characterized by bilateral,
alcohol-sensitive myoclonic jerks primarily involving the neck, trunk,
and upper limbs, frequently accompanied by cervical and/or brachial
dystonia.12,14 A mutation in SGCE accounts for 30–40% of typical
presentations; it is inherited in an autosomal dominant fashion and
maternally imprinted.14,15 MDS is clinically heterogeneous, with some
phenotypes of isolated dystonia16–18 or isolated myoclonus.17,18 The
origin of the myoclonus in MDS remains ambiguous, though electro-
physiologic and functional imaging investigations implicate a subcortical
process.14,18–20 Symptom onset in MDS is typically in childhood or early
adolescence.14 Psychiatric comorbidities, such as obsessive-compulsive
disorder, are increasingly recognized.14,16 Cognitive impairment is not a
feature of the disease.14
In MDS, myoclonus has only infrequently been reported to affect
speech.21 In a large family with a deletion in exon 7 of SGCE, six of
nine affected patients displayed laryngeal myoclonus affecting speech,
described as ‘‘discrete, non-rhythmic jumps in the voice.’’21 Another
large kindred with MDS in the northwestern United States noted six of
10 affected family members exhibited facial myoclonus, though its
impact upon their speech was not elucidated.22 Our patient
demonstrated speech-activated myoclonus that was most pronounced
while reading aloud as opposed to speaking spontaneously. Speech-
activated myoclonus is typically a function of the type of speech:
spontaneous or rote.5 In their case series, Slee et al.5 demonstrated that
oropharyngeal movements not involving the vocal cords (e.g. whistling,
chewing, swallowing) failed to trigger myoclonus. The authors also
noted that ‘‘internal speech’’ and writing did not activate myoclonus,
concluding that in all three patients, the myoclonus was elicited by
vocal speech production.5
In summary, we present a patient with a genetic type of dystonia,
MDS, with speech-activated myoclonus mimicking stuttering, further
expanding the spectrum of conditions causing this rare clinical
phenomenon.
Video 1. Neurologic Examination Demonstrating Speech-activated
Myoclonus. The patient has moderate-severe retrocollis and mild laterocollis to
the left, with irregular hyperkinetic head and neck movements during attempted
head rotation, consistent with superimposed cervical action myoclonus.
Myoclonus can also be seen affecting the face and arms. Spontaneous speech is
relatively normal in this video segment. While reading, the patient’s speech is
frequently interrupted by synchronous myoclonus involving the neck, orbicularis
oculi, and vocal musculature.
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